Both in Pharmaceuticals
Valion Bio vs Artelo Biosciences
Over the past year VBIO returned −75.7% and ARTL returned −59.1%; their daily moves had a correlation of 0.07.
VBIO −75.7% ARTL −59.1%Growth of $1, one year, split-adjusted
| Metric | VBIO | ARTL |
|---|---|---|
| Price | $0.5500 | $2.22 |
| Market cap | $1.2M | $1.2M |
| Today | −10.83% | −3.90% |
| 1 month | −78.1% | −42.0% |
| 6 months | — | −92.7% |
| Year to date | — | −93.3% |
| 1 year | — | −97.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$5.3M | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 650.2% |
| Short % of float | 9.4% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).